Xuchang war pigeon clan trading co., Ltd. – Trademark Portfolio

Entity Type: 16

Xuchang war pigeon clan trading co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include GORGEOUSU. The owner is based in Henan Province.

15 / F, IFC Financial Center, Block D

Weowen Road Wealth Center, Xuchang City

Henan Province 461000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

GORGEOUSU
GORGEOUSU
Registered 2019

Trademark Classifications

Xuchang war pigeon clan trading co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Xuchang war pigeon clan trading co., Ltd. have?

Xuchang war pigeon clan trading co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Xuchang war pigeon clan trading co., Ltd. file in?

Xuchang war pigeon clan trading co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Xuchang war pigeon clan trading co., Ltd.'s most well-known trademarks?

Xuchang war pigeon clan trading co., Ltd.'s registered trademark portfolio includes well-known marks such as GORGEOUSU. These are among 1 currently registered trademark in the portfolio.

What is Xuchang war pigeon clan trading co., Ltd.'s trademark registration success rate?

Xuchang war pigeon clan trading co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.